Stomach Cancer Market Scope And Analysis

  • Report Code : TIPRE00004053
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Stomach Cancer Market Scope and Analysis by 2030

Buy Now

Stomach Cancer Market Report Stomach Cancer Market Size and Share Stomach Cancer Market Scope and Analysis

Stomach Cancer Market Report Scope

Report Attribute Details
Market size in 2022 US$ 3,575.04 Million
Market Size by 2030 US$ 10,751.42 Million
Global CAGR (2022 - 2030) 14.8%
Historical Data 2020-2022
Forecast period 2022-2030
Segments Covered By Type
  • Adenocarcinomas
  • Gastrointestinal Stromal Tumors
  • Neuroendocrine Tumors
  • Lymphoma
By Treatment
  • Targeted and Immunotherapy Drugs
  • Chemotherapy and Combination Drugs
By Route of Administration
  • Oral
  • Parenteral
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Bristol Myers Squibb Company
  • Novartis AG
  • Merck Co Inc
  • Eli Lilly and Company
  • Biocon
  • Teva Pharmaceutical Industries Ltd
  • Celltrion Healthcare Co Ltd
  • Samsung Bioepis
  • Pfizer Inc

    • Industry Developments and Future Opportunities: 

    Numerous initiatives taken by key players operating in the global stomach cancer market are listed below:

    • In January 2021, AstraZeneca and Daiichi Sankyo Company received the approval of Enhertu from the US FDA for treating adult patients with advanced or metastatic HER2-positive gastric adenocarcinoma.

    Competitive Landscape and Key Companies:

    Bristol Myers Squibb Company; Novartis AG; Merck & Co., Inc.; Eli Lilly and Company; Biocon; Teva Pharmaceutical Industries Ltd; Celltrion Healthcare Co., Ltd; Samsung Bioepis; Pfizer Inc.; and Ipsen Pharma are among the prominent players in the stomach cancer market. These companies focus on introducing new high-tech products, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.